logo

For the Inventor, By the Inventor

Cedar Grove, NJ, United States of America

Ann C Sullivan

USPTO Granted Patents = 15

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 89(Granted Patents)


Location History:

  • New York, NY (US) (1976)
  • Cedar Grove, NJ (US) (1978 - 1988)

Company Filing History:

goldMedal15 out of 4,948 
 
Hoffmann-la Roche Inc.
 patents

Years Active: 1976-1988

Loading Chart...
15 patents (USPTO):Explore Patents
1. 4731363 - Thromboxane synthase inhibitors as insulin lowering agents and (1988-03-15),
2. 4591594 - Thromboxane synthase inhibitors as antiobesity agents (1986-05-27),
3. 4500540 - Thromboxane synthase inhibitors as insulin lowering agents and (1985-02-19),
4. 4443619 - Chlorocitric acids (1984-04-17),
5. 4365070 - Chlorocitric acids (1982-12-21),
6. 4354039 - Chlorocitric acids (1982-10-12),
7. 4352758 - Chlorocitric acids (1982-10-05),
8. 4340754 - Process for making chlorocitric acid (1982-07-20),
9. 4312885 - Chlorocitric acids (1982-01-26),
10. 4302450 - Polyether ionophores as antiobesity and hypotriglyceridemic agents (1981-11-24),
11. 4218443 - Polyether ionophores as antiobesity and hypotriglyceridemic agents (1980-08-19),
12. 4117121 - Method of increasing bile flow and decreasing lipid levels (1978-09-26),
13. 4107188 - Pregnanes (1978-08-15),
14. 4104285 - Taurine and glycine derivatives (1978-08-01),
15. 3966772 - Citric acid derivatives (1976-06-29),

Title: Ann C Sullivan: Pioneering Innovator in Thromboxane Synthase Inhibitors

Introduction

Ann C Sullivan, a remarkable inventor based in Cedar Grove, NJ, has made significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of 15 patents, she has established herself as a key player in the development of innovative compounds aimed at addressing obesity and insulin resistance.

Latest Patents

Among Ann's latest patents are groundbreaking inventions related to thromboxane synthase inhibitors which serve dual roles as insulin-lowering agents and antiobesity agents. These patents focus on a diverse range of compounds, including 1-substituted imidazoles, 4-substituted imidazoles, 3-substituted pyridines, 3-substituted indoles, 4-substituted pyrimidines, 5-substituted tetrazoles, pyrazolidines, quinazolines, and substituted xanthene carboxylic acids. This innovative work reflects Ann's commitment to advancing health and wellness through targeted pharmacological solutions.

Career Highlights

Ann C Sullivan has built an impressive career at Hoffmann-La Roche Inc., where she has dedicated her efforts to research and development in biotechnology and medicine. Her expertise in synthesizing complex molecules has enabled her to contribute to various therapeutic areas, particularly focusing on diabetes and obesity-related disorders.

Collaborations

Throughout her career, Ann has collaborated with esteemed colleagues, including Robert W Guthrie and Richard W Kierstead. These partnerships have fostered a vibrant exchange of ideas and research methodologies, further enhancing the quality and impact of their collective work in the field.

Conclusion

In conclusion, Ann C Sullivan stands out as a pivotal figure in the realm of pharmaceutical innovations. Her relentless pursuit of solutions to pressing health issues exemplifies the critical role of inventors in shaping the future of medicine. As she continues her work at Hoffmann-La Roche Inc., the medical community eagerly anticipates her future breakthroughs and contributions to the field of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…